APA (7th ed.) Citation

W, G., B, L., L, T., L, P., & S, G. (2026). Reduced-dose anti-thymocyte globulin combined with post-transplant cyclophosphamide versus standard ATG for graft-versus-host disease prophylaxis in haploidentical hematopoietic stem cell transplantation: A focus on chronic GVHD reduction. Leukemia & lymphoma, 67(6), 1385. https://doi.org/10.1080/10428194.2026.2645932

Chicago Style (17th ed.) Citation

W, Guo, Li B, Tang L, Peng L, and Guo S. "Reduced-dose Anti-thymocyte Globulin Combined with Post-transplant Cyclophosphamide Versus Standard ATG for Graft-versus-host Disease Prophylaxis in Haploidentical Hematopoietic Stem Cell Transplantation: A focus on Chronic GVHD Reduction." Leukemia & Lymphoma 67, no. 6 (2026): 1385. https://doi.org/10.1080/10428194.2026.2645932.

MLA (9th ed.) Citation

W, Guo, et al. "Reduced-dose Anti-thymocyte Globulin Combined with Post-transplant Cyclophosphamide Versus Standard ATG for Graft-versus-host Disease Prophylaxis in Haploidentical Hematopoietic Stem Cell Transplantation: A focus on Chronic GVHD Reduction." Leukemia & Lymphoma, vol. 67, no. 6, 2026, p. 1385, https://doi.org/10.1080/10428194.2026.2645932.